Cargando…
In Silico Methods in Antibody Design
Antibody therapies with high efficiency and low toxicity are becoming one of the major approaches in antibody therapeutics. Based on high-throughput sequencing and increasing experimental structures of antibodies/antibody-antigen complexes, computational approaches can predict antibody/antigen struc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640671/ https://www.ncbi.nlm.nih.gov/pubmed/31544874 http://dx.doi.org/10.3390/antib7030022 |
_version_ | 1783436619344248832 |
---|---|
author | Zhao, Jun Nussinov, Ruth Wu, Wen-Jin Ma, Buyong |
author_facet | Zhao, Jun Nussinov, Ruth Wu, Wen-Jin Ma, Buyong |
author_sort | Zhao, Jun |
collection | PubMed |
description | Antibody therapies with high efficiency and low toxicity are becoming one of the major approaches in antibody therapeutics. Based on high-throughput sequencing and increasing experimental structures of antibodies/antibody-antigen complexes, computational approaches can predict antibody/antigen structures, engineering the function of antibodies and design antibody-antigen complexes with improved properties. This review summarizes recent progress in the field of in silico design of antibodies, including antibody structure modeling, antibody-antigen complex prediction, antibody stability evaluation, and allosteric effects in antibodies and functions. We listed the cases in which these methods have helped experimental studies to improve the affinities and physicochemical properties of antibodies. We emphasized how the molecular dynamics unveiled the allosteric effects during antibody-antigen recognition and antibody-effector recognition. |
format | Online Article Text |
id | pubmed-6640671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66406712019-09-05 In Silico Methods in Antibody Design Zhao, Jun Nussinov, Ruth Wu, Wen-Jin Ma, Buyong Antibodies (Basel) Review Antibody therapies with high efficiency and low toxicity are becoming one of the major approaches in antibody therapeutics. Based on high-throughput sequencing and increasing experimental structures of antibodies/antibody-antigen complexes, computational approaches can predict antibody/antigen structures, engineering the function of antibodies and design antibody-antigen complexes with improved properties. This review summarizes recent progress in the field of in silico design of antibodies, including antibody structure modeling, antibody-antigen complex prediction, antibody stability evaluation, and allosteric effects in antibodies and functions. We listed the cases in which these methods have helped experimental studies to improve the affinities and physicochemical properties of antibodies. We emphasized how the molecular dynamics unveiled the allosteric effects during antibody-antigen recognition and antibody-effector recognition. MDPI 2018-06-29 /pmc/articles/PMC6640671/ /pubmed/31544874 http://dx.doi.org/10.3390/antib7030022 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Zhao, Jun Nussinov, Ruth Wu, Wen-Jin Ma, Buyong In Silico Methods in Antibody Design |
title | In Silico Methods in Antibody Design |
title_full | In Silico Methods in Antibody Design |
title_fullStr | In Silico Methods in Antibody Design |
title_full_unstemmed | In Silico Methods in Antibody Design |
title_short | In Silico Methods in Antibody Design |
title_sort | in silico methods in antibody design |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640671/ https://www.ncbi.nlm.nih.gov/pubmed/31544874 http://dx.doi.org/10.3390/antib7030022 |
work_keys_str_mv | AT zhaojun insilicomethodsinantibodydesign AT nussinovruth insilicomethodsinantibodydesign AT wuwenjin insilicomethodsinantibodydesign AT mabuyong insilicomethodsinantibodydesign |